Scientific Programme
FRIDAY 4 November 2011
08:45–09:00 Symposium opening
S. Nevšímalová, H. Chugani, V. Komárek
09:00–10:40 Chair: S. Nevšímalová (Czech Republic), H. Chugani (USA)
Advanced neuroimaging in pediatric neurological disorders (20′)
H. Chugani (USA)
Imaging studies in childhood language problems (20′)
L. Lagae (Belgium)
Neurobiology of autism (20′)
P. Curatolo (Italy)
Current status of novel therapies for cerebral palsy (20′)
M. Shevell (Canada)
Connectomics and neurodevelopmental disorders (10′)
V. Komárek (Czech Republic)
10:40–11:00 Coffee break
11:00–12:20 Chair: I.Tein (Canada), L. Lagae (Belgium)
Update in the treatment of mitochondrial disorders (20′)
I. Tein (Canada)
Neurometabolic disorders and epilepsy (20′)
L. De Meirleir (Belgium)
Movement disorders in children (25′)
M. Segawa (Japan)
Movement disorders with dystonia in childhood (10′)
J. Kraus (Czech Republic)
12:20–13:00 Break / Poster Session (Moderator: P. Kršek)
13:00–14:50 Chair: A. Galanopoulou (USA), S. Jóźwiak (Poland)
New therapeutic strategies in TSC-associated epilepsy (20′)
S. Jóźwiak (Poland)
The follow-up of children with congenital cardiac rhabdomyomas, prenatal and perinatal risk factors and early diagnosis of the tuberous sclerosis and epilepsy (10′)
B. Petrák (Czech Republic)
Epilepsy surgery in patients with TSC (10′)
P. Kršek (Czech Republic)
Discussion
Treatment of early epileptic encephalopathies (20′)
R. Riikonen (Finland)
Rapamycin therapy for infantile spasms (20′)
A. Galanopoulou (USA)
Argentine experience with ketogenic diet in different epileptic syndromes (20′)
G. Agosta (Argentina)
Discussion
14:50–15:30 Coffee break
15:30–17:10 Chair: O. Eeg-Olofsson (Sweden), K. Mack (USA)
Advances and clinical trials in Charcot-Marie-Tooth disease (20′)
J. Wilmshurst (South Africa)
10 years outcome of childhood epilepsy (20′)
O. Eeg-Olofsson (Sweden)
Chronic Daily Headache (20′)
K. Mack (USA)
Stroke in different arterial territories. Are the risk factors different? (25′)
H. Arroyo (Argentina)
Sturge-Weber syndrome, epilepsy and cognitive functions? (15′)
C. Juhasz (USA)
SATURDAY 5 November 2011
08.30–10:40 Chair: B. Anlar (Turkey), P. Mareš (Czech Republic)
Autoimune CNS disorders in children (20′)
R. Rust (USA)
Antibody-mediated encephalitis in children (20′)
A. Anlar (Turkey)
Narcolepsy – a new autoimmune disease? (20′)
S. Nevšímalová (Czech Republic)
CNS infections and epilepsy (25′)
P. Singhi (India)
Inflammation, epilepsy, and behavior (25′)
R. Sankar (USA)
Adenosine A1 receptors – a target for an age-dependent anticonvulsant therapy? (10′)
P. Mareš (Czech Republic)
Neuroprotective treatment during development – effects of free radical scavenger N-tert-butyl-alfa-phenylnitrone on consequences of status epilepticus (10′)
H. Kubová (Czech Republic)
10:40–11:15 Coffee break
11:15–12:30 Chair: R. Ouvrier (Australia), P. Sýkora (Slovak Republic)
Acute and chronic inflammatory polyradiculopathies of child-hood (20′)
R. Ouvrier (Australia)
Congenital muscular dystrophies (20′)
J. Vajsar (Canada)
X-linked Emery Dreifuss muscular dystrophy: phenotypic ex-pression of a novel c.386 G>C (p.C129S) mutation in four and a half LIM domains protein 1 gene (FHL1 gene) (10′)
J. Haberlová (Czech Republic)
Abnormal distribution of GABAergic interneurons in X-linked lissencephaly with abnormal genitalia (10′)
M. Itoh (Japan)
Electrophysiological findings in patients with autosomal dominant ataxias (10′)
A. Zumrová, J. Kraus (Czech Republic)